Slight increase in Denmark's 1994 health spending:
This article was originally published in Clinica
Executive Summary
Total spending on healthcare in Denmark rose 2.2% to DKr 60,553 million ($11,000 million) in 1994, reports MEFA, the Danish pharmaceutical industry association. Of this, the hospital sector accounted for DKr 37,370 million or 61.7% (including DKr 922 million spent on hospital construction during the year). The government contributed 83% of overall health spending, the remainder being paid directly by the public. Healthcare expenditure as a percentage of Denmark's GDP has been declining in recent years. In 1994, it accounted for 6.5%, MEFA notes.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.